Merck (NYSE: MRK) is a research-driven, global drug manufacturer. It is headquartered in Whitehouse Station, New Jersey and was founded in 1891.
Not to be confused with Merck KGaA (a German company), Merck is a globe-spanning pharmaceutical company with many different drugs sold in 140 different countries. Perhaps most famous for Vioxx, a now discontinued pain medication, the company has many successful, safe prescription products.
With annual revenue of over $20 billion, it is one of the largest pharmaceutical companies in the world. Approximately 60% of its revenue comes from the United States. The company has paid an uninterrupted dividend since at least 1970, though it has not increased it every year.
Major products include the following:
- Cozaar / Hyzaar -- treatment of hypertension (high blood pressure)
- Fosamax -- treatment for osteoporosis
- Gardasil -- vaccine for human papilloma virus, which can cause cervical cancer and genital warts
- Januvia -- treatment of type 2 diabetes
- Singulair -- treatment of asthma and the single biggest selling product for the company
- Vytorin -- treatment of high cholesterol
The company also has products to treat HIV, male pattern hair loss, acute migraine, chemotherapy-induced nausea, and preventive vaccines for children (e.g. measles, mumps, and rubella).
The company is also involved in animal care.
Chairman, CEO, and President: Richard T. Clark
CFO: Peter N. Kellogg
Recent Mentions on Fool.com
- Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too
- This Tiny Biotech Is Piggybacking on Gilead Sciences, Inc.'s Success
- Danger Lurking in Merck Stock's Dividend Payout Ratio Analysis?
- Merck & Co., Inc. Earnings: Patent Losses and Competition Weigh on Sales
- A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline